SMO and medulloblastoma: For example in a mouse model of medulloblastoma, addition of PI3K inhibitor BKM120 or PI3K/mTOR inhibitor BEZ235 to the initial treatment with SMO inhibitor LDE225 markedly delayed the occurrence of resistance [47].